You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Roche pays $220m for Westborough company

Swiss diagnostics and drug company Roche bought the Westborough blood testing company Constitution Medical Investors for $220 million on Tuesday.

Roche, which calls itself the world’s largest biotech company, will utilize Constitution Medical Investors’ Bloodhound, a blood testing technology that is designed to provide fast and accurate diagnosis of blood-related diseases. Bloodhound, a device currently in development and not yet approved by the Food and Drug Administration, is the core technology of an automated system that has the capacity to increase laboratory efficiency and to save space.

Continue reading below

CMI is a health care investment firm that focuses on early-stage technology funding, specifically with medical devices and testing that diagnoses disease and infection.

In addition to the $220 million paid upfront, the deal also includes the possibility of more payments, depending on whether or not the company reaches “certain milestones,” according to the agreement.

Gail Waterhouse can be reached at gail.waterhouse@globe.com. Follow her on Twitter at @gailwaterhouse.
Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.